Competence for Telemedicine and Medical Technology

MSU Stemo

Scientifically proven: Better chances for patients with acute stroke due to prehospital treatment within Mobile Stroke Units (MSU), which delivers relevant research information as Stroke-Einsatz-Mobile (STEMO) model from Berlin

02 February 2021: the results of the B_PROUD study were published in the scientific journal JAMA* and presented at a press conference situated in Charité. The Berlin team led by Prof. Dr. med. Heinrich Audebert (Deputy Clinical Director of Neurology at Charité Universitätsmedizin Berlin) has already presented the results of the clinical study B_PROUD (the Berlin - Pre-hospital Or Usual care Delivery) at the annual International Stroke Conference from 19th to 21th of February 2020 in Los Angeles (USA, California). According to the results, early pre-hospital diagnosis and intervention utilizing MSUs/STEMOs, which are specially equipped with both trained medical staff and necessary diagnostic capabilities, leads to the 26% fewer deaths and disability rates in the acute stroke patients than among patients whose treatment only begins in a hospital. This is all the more remarkable because in Berlin alone, stroke care can certainly be considered very well developed compared to other regions, with 83 hospitals (figures 2017, Berlin-Brandenburg hospital plan 2020) and 16 regional and supra-regional stroke units (figures 2016, Berlin hospital plan 2016). In summary, the affected stroke patients located in the metropolitan areas and especially in rural areas would benefit from this concept in the future.

The prehospital stroke care concept Stroke-Einsatz-Mobil (STEMO) was developed by the Charité-Universitätsmedizin Berlin and the Berlin Fire Brigade together with MEYTEC. The technical support and supervision in the box body including CT scanner, laboratory equipment and extensive telemedical equipment as well as the necessary server infrastructure is provided by MEYTEC GmbH.

*Ebinger M et al., Association Between Dispatch of Mobile Stroke Units and Functional Outcomes Among Patients With Acute Ischemic Stroke in Berlin. JAMA 2021;325(5):454-466. doi: 10.1001/jama.2020.26345
Literature: Audebert H.: Effects of Pre-hospital Acute Stroke Treatment as Measured with the Modified Rankin Scale; the Berlin - Pre-hospital Or Usual care Delivery (B_PROUD) trial, presented on February 20, 2020 at the International Stroke Conference (ISC) 2020, February 19-21, 2020, Los Angeles

Prof. Dr. med. Heinrich Audebert in an interview with MEDICA.de
In an interview with MEDICA.de, Prof. Heinrich Audebert, Deputy Clinical Director of Neurology at Charité Universitätsmedizin Berlin, speaks about the occasion, approach and goal of the study on mobile stroke units.
medica.de/de/News/Thema_des_Monats/../Mobile_Stroke_Units_besseres_Outcome_nach_Schlaganfall

More Information:
Charité press releases Schlaganfall: Bessere Prognose bei Einsatz von Stroke-Einsatz-Mobilen,
Stimmen zum STEMO: Pressekonferenz zu 10 Jahren Stroke-Einsatz-Mobil
DSG press release Neue Studie: Mobile Stroke Units verbessern Chancen von Schlaganfallpatienten gravierend
Article on rettungsdienst.de Studie: Mobile Stroke Units verbessern Chancen bei Schlaganfall
stemo-info.de


ePrivacyseal - EU Data protection

MEYDOC® gets the ePrivacyseal EU data protection seal

At the start of 2021, the MEYTEC telemedicine solution MEYDOC® was awarded the ePrivacyseal EU data protection seal. MEYDOC® is a solution for secure end-to-end encrypted video communication in the medical environment. By achieving this seal of approval, through the independent certification company ePrivacy GmbH, MEYTEC has ensured that the MEYDOC® solution conforms with the associated processes and strict criteria relating to EU data protection law (EU-GDPR). The ePrivacyseal EU was awarded following an in-depth technical and legal review of all relevant system components and associated product documentation. In addition to the certification of a quality management system in accordance with DIN EN ISO 13845:2016, the data protection seal (ePrivacyseal EU)* provides reassurance for MEYTEC customers when choosing its telemedicine products. This is further evidence that MEYTEC is committed to complying with and respecting applicable EU data protection principles in the secure design of its products and the processes involved.
*Important note: The ePrivacyseal EU confirms compliance with the ePrivacyseal criteria catalogue, which includes the requirements of EU data protection law in accordance with the EU General Data Protection Regulation. It is not an accredited certification procedure in the sense of Artt. 42 and 43 EU-GDPR. Find out more at eprivacy.eu


Berlin cert

Successfully launched quality management acc. to the DIN EN ISO 13485:2016

MEYTEC GmbH Informationssysteme and MEYTEC GmbH Medizinsysteme have successfully implemented the quality management system for “Development, manufacturing, sale and service of telemedicine products as well as sale and service of medical devices”. The certification body Berlin Cert Prüf- und Zertifizierstelle für Medizinprodukte GmbH has confirmed, that both companies comply with the requirements of the norm DIN EN ISO 13845:2016. G.W. Meyer, CEO of both companies, commented: “The completed certification is a significant part of our strategy for the upcoming years, because our increasing focus is the development of new telemedicine products and further development of the established telemedicine systems”.
Werneuchen, 10.08.2020

news.meytec.com

News

Telemedizin für Rettungseinsätze, Dietmar Woidge besucht HVL Klinik Nauen

Telemedicine for paramedic services

On 16.09.2020, the Minister-President of Brandenburg, Dietmar Woidke visited the Havelland Clinic in Nauen, accompanied by Roger Lewandowski, the councilor of the Havelland District. The paramedic service in Havelland has been equipped with a special telemedicine workstation as well as new ambulance fitted technology that delivers an innovative tele-emergency doctor concept, based on an existing Bavarian model. The alerted paramedics can now be connected live to a tele-emergency doctor via telemedicine in the ambulance until an emergency doctor arrives or delegates measures to the paramedics on site. For this purpose, the tele-emergency doctors have access to vital signs data and real-time audiovisual communication from the ambulance to their telemedicine workstations. All measures are largely automated in a context-sensitive system and documented in a legally compliant manner.

Read further information online at moz.de, by Sandra Euent, 17.09.2020, Dietmar Woidke visiting the Havelland-Klinik Nauen (in German)


ambulance

National Stroke Week in Australia. Interview about telemedicine service VST

The role of Ambulance Victoria’s VST - Victorian Stroke Telemedicine Service, in the diagnosis and care of acute stroke, should not be underestimated. The VST service, is unique in Australia, and has helped thousands of Victorian patients since 2014 at 17 regional hospitals, as well as two additional regional centres in Tasmania added earlier this year. Speaking in recent radio interviews, during National Stroke Week (Australia), the Director of Stroke Services at Ambulance Victoria Prof. Chris Bladin, spoke about how this ground breaking service has transformed the way clinicians collaborate to deliver the best care possible to stroke patients, irrespective of their location. MEYTEC is the provider of the cutting edge telemedicine solution that enables the on-call neurologist to examine the stroke patient remotely, as well as speak to hospital staff and family members at the bedside 24/7. The integration of telemedicine into the hyper-acute stroke treatment pathway, has undoubtedly enhanced the long-term outcome of patients.

m.soundcloud.com, 030920 ABC Loomes and Bladin - Ambulance Victoria


meydoc

Telemedicine service for the home care of patients with Multiple Sclerosis in Umbria

A new telemedicine service for patients with Multiple Sclerosis will be set up in the Italian region Umbria providing video based consultations at home. The technological partner MEYTEC will deliver their MEYDOC® solution for the aftercare of patients in their home environment by clinicians. The patients at home can use the MEYDOC® Client App on their private smartphones and tablets for free. The clinician uses the Windows™ based software MEYDOC® Master, that can enable a multipoint session with up to 16 participants simultaneously. The new telemedicine services will be provided to around 300 patients located in the region.

Telemedicina per affetti da sclerosi | 24.03.2020, ANSA - FOLIGNO (PERUGIA)

Further information: meydoc.de


 

Meet us at professional events and congresses

Pinboard

 

MEYTEC GmbH Medizinsysteme

MEYTEC’s competence in telemedicine and eHealth results from the continual investment and development in innovative systems and services. This philosophy coupled with extensive experience in the integration of telemedical applications in Germany and Europe, as well as, intensive cooperation with physicians in practice, has kept the company at the forefront of the field.


  • Telemedizinsysteme
  • Telemedizin Lösungen
  • Telemedizinnetz medMnet
  • Technischer Support
  • Telemedizin Projekte
  • Media, Video- und Audio-Beitraege

 

Press

Ärzte Zeitung | 08.03.2021
Neurologen bieten Palliativ-Teams digitale Unterstützung am Krankenbett

Das Klinikum Agatharied ermöglicht ambulanten Pflegern und Hospizen, virtuell mit Neurologen Symptome zu besprechen. Zukünftig sollen alle Palliativ-Teams in Bayern das Angebot nutzen können...
Beitrag auf aerztezeitung.de


Deutsche Gesellschaft für Neurologie (DGN) | 02.03.2021
Mobile Stroke Unit führt zu weniger Behinderungen nach Schlaganfall

Schlaganfälle sind eine der häufigsten Ursachen für bleibende Behinderungen bei Erwachsenen. Ursache für ein schlechtes Outcome ist, dass oft zu viel Zeit zwischen dem Einsetzen der Symptome und der Einleitung der Notfalltherapie verstreicht. Eine aktuelle Studie zeigte nun, dass es durch den Einsatz sogenannter mobiler Stroke Units (STroke Einsatz-MObile = STEMO) Zeit gespart wird und es dadurch seltener zu schweren Behinderungen und Todesfällen kommt. „Es ist ein wichtiges Ziel der Neurologie, dass möglichst viele Patientinnen und Patienten einen Schlaganfall unbeschadet überstehen.“...
Beitrag auf dgn.org/..


Gesundheitsstadt Berlin | 10.02.2021
Bessere Prognose nach Schlaganfall: Gutes Zeugnis für Berliner Stroke Mobil STEMO

Die Stroke-Einsatz-Mobile in Berlin leisten Erste Hilfe bei Schlaganfall. Jetzt wurde gezeigt: Die Patienten haben bessere Chancen, ihren Schlaganfall ohne bleibende Behinderung zu überleben...
Beitrag auf gesundheitsstadt-berlin.de/..


BZ Berlin | 09.02.2021
Charité-Studie belegt. Das STEMO – Berlins schnellste Hilfe bei Schlaganfällen

von Birgit Bürkner
Bei einem Schlaganfall zählt jede Minute. Eine Charité-Studie zeigt: Werden Betroffene in einer mobilen Schlaganfallklinik (STEMO) behandelt, haben sie eine bessere Prognose!
„Wir konnten belegen, dass Schlaganfall-Betroffene, zu deren Rettung das STEMO losgeschickt wurde, häufiger überlebten und seltener eine Behinderung davontrugen“, sagt Studienleiter Charité-Professor Heinrich Audebert...
Beitrag auf bz-berlin.de/..


idw - Informationsdienst Wissenschaft | 08.02.2021
Schlaganfall: Bessere Prognose bei Einsatz von Stroke-Einsatz-Mobilen

von Manuela Zingl, GB Unternehmenskommunikation
Sie sind seit 10 Jahren in Berlin unterwegs: die Stroke-Einsatz-Mobile (STEMO). Die speziell ausgestatteten Rettungsfahrzeuge erlauben es, Menschen bei einem Schlaganfall schon am Einsatzort zu behandeln. Ein Forschungsteam der Charité – Universitätsmedizin Berlin hat jetzt erstmals gezeigt, dass die Betroffenen beim Einsatz der STEMO eine bessere Prognose haben: Sie überleben häufiger ohne bleibende Behinderung. Die Ergebnisse der Studie sind im Fachmagazin JAMA* veröffentlicht...
Beitrag auf idw-online.de/..


esanum.de | 27.01.2021
Schlaganfallsterblichkeit in den letzten 15 Jahren halbiert

Das Motto des Weltschlaganfalltages am 29. Oktober 2020 war „Get ready to dance like no-one is watching. Join the MoveMent to prevent stroke“. Und auf dem 93. Kongress der Deutschen Gesellschaft für Neurologie, der an diesem Tag stattgefunden hat, war die Schlaganfalltherapie eines der Kernthemen. Der DGN-Kongresspräsident Prof. Dr. Matthias Endres, Charité – Universitätsmedizin Berlin, berichtete, dass die Schlaganfallsterblichkeit in Deutschland in den vergangenen 15 Jahren halbiert werden konnte. Es wurde auch viel über STEMO, die Mobilen Stroke Units, die in der Hauptstadt als Stroke-Einsatz-Mobile im Einsatz sind berichten. Dank STEMO haben die Patienten eine höhere Chance, den Schlaganfall unbeschadet zu überstehen.
Lesen Sie mehr unter esanum.de/..